PLUR:NASDAQ
Pluri Inc
၂.၃၁ US$
arrow_downward
-၂.၁၂%(-၀.၀၅၀) 1D
ဇွန် ၈, GMT-၄ ၁၆:၀၀:၀၀ · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PLUR...
Open
၂.၃၈ US$
High
၂.၃၈ US$
Low
၂.၃၀ US$
Mkt. cap
၂.၄၉ ကုဋေ
Avg. vol.
၁.၄၀ သောင်း
Volume
၀.၀၀
52-wk high
၅.၉၆ US$
52-wk low
၂.၂၂ US$
EPS
-၂.၈၉ US$
Beta
၀.၆၄
Shares outstanding
၁.၀၈ ကုဋေ
No. of employees
၁၃၅
Open
၂.၃၈ US$
High
၂.၃၈ US$
Low
၂.၃၀ US$
Mkt. cap
၂.၄၉ ကုဋေ
Avg. vol.
၁.၄၀ သောင်း
Volume
၀.၀၀
52-wk high
၅.၉၆ US$
52-wk low
၂.၂၂ US$
EPS
-၂.၈၉ US$
Beta
၀.၆၄
Shares outstanding
၁.၀၈ ကုဋေ
No. of employees
၁၃၅
News stories
From sources across the web
Value The Markets
·
ပြီးခဲ့သည့် ၁၂ မိနစ်
Campbell's (NASDAQ: CPB) Reports Q3 Adjusted EPS Down 32%
BeBeez International
·
ပြီးခဲ့သည့် ၃၀ မိနစ်
Bending Spoons files with SEC for an above 4 billion US Dollars Nasdaq IPO
Yahoo Finance
·
ပြီးခဲ့သည့် ၁၁ နာရီ
Marvell is joining the S&P 500 — but history says the early bump comes with a big catch: Chart of the Day
Electrek
·
ပြီးခဲ့သည့် ၁၅ နာရီ
Solid-state EV battery maker debuts on Nasdaq after 745+ mile range real-world test
Profile
Pluri Inc., formerly Pluristem Therapeutics, is an Israeli company engaged in the development of human placental adherent stromal cells for commercial use in disease treatment. According to the company's website, it extracts adult stem cells exclusively from postnatal placentas. Wikipedia
About Pluri Inc
CEOYaky Yanay
Employees၁၃၅
Founded၂၀၀၁ မေ ၁၁
Headquartersဟိုင်ဖ, Haifa District, အစ္စရေး
Sector-
Websitepluri-biotech.com
AI content may include mistakes. Learn more